Your browser doesn't support javascript.
loading
Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial.
Moser, Carlee B; Chew, Kara W; Ritz, Justin; Newell, Matthew; Javan, Arzhang Cyrus; Eron, Joseph J; Daar, Eric S; Wohl, David A; Currier, Judith S; Smith, Davey M; Hughes, Michael D.
Afiliación
  • Moser CB; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Chew KW; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Ritz J; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Newell M; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Javan AC; Division of AIDS/National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
  • Eron JJ; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Daar ES; Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
  • Wohl DA; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Currier JS; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Smith DM; Department of Medicine, University of California, San Diego, La Jolla, California, USA.
  • Hughes MD; Department of Biostatistics and Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
J Infect Dis ; 228(Suppl 2): S92-S100, 2023 08 31.
Article en En | MEDLINE | ID: mdl-37650234

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Infect Dis Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Infect Dis Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos